. registration with Food and Drug Administration (FDA), trademark permission, product and packaging design, and brand building etc. to customers who are business operator in skin cares and cosmetics. In addition

issued from China Food and Drug Administration (CFDA) at the beginning of 2018 as the Company had to redesign its packaging to comply with the requirements of the license and adjust its sales structures

the issuer’s core business. In any event, the issuer must not operate business in such a way that involves severely illegal business. For example, human trafficking, drug production or smuggling, or

baht or 6. 56 percent from the previous year, mainly due to a decrease of drug and medical supply cost since the volume of general patients and social security patients decreased. Besides, the Company

involves severely illegal business. For example, human trafficking, drug smuggling or money laundering etc. Moreover, the issuer must not act in violation or non-compliance with the law, which may cause

purpose of use of proceeds 5. Expansion of production capacity for dietary supplement products, introduction of new product packages, and warehouse building (existing business as disclosed in the

financial institutions 50 50 50 - 2018 4. Working capital for business operations 637.24 637.24 368.34 - 2018-2020 Newly – approved of purpose of use of proceeds 5. Expansion of production capacity for

higher competition. The company recorded revenue from services of 579.03 million Baht which increased from the last year totaling 431.89 million Baht or 293.52% due to the expansion of construction

by Baht 11.33 million or 2.40 % due to the Medical personal expenses increased from the expansion of the subsidiaries. 3.Administrative expenses increased by Baht 29.82 million or 30.84 % due to the

through this channel will help facilitate their business expansion and development as well as foster their competitive edge at domestic and international levels. To this end, more jobs would be created and